Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: To compare glycemic variability (GV) indices between patients with fibrocalculous pancreatic diabetes (FCPD) and type 2 diabetes mellitus (T2D) using continuous glucose monitoring (CGM). Methods: We measured GV indices using CGM (iPro™2 Professional CGM, Medtronic, USA) data in 61 patients each with FCPD and T2D who were matched for glycated hemoglobin A1c (HbA1c) and duration of diabetes. GlyCulator2 software was used to estimate the CGM-derived measures of GV (SD, mean amplitude of glycemic excursion [MAGE], continuous overall net glycemic action [CONGA], absolute means of daily differences [MODD], M value, and coefficient of variance [%CV]), hypoglycemia (time spent below 70 mg/dL, AUC below 70 mg/dL, glycemic risk assessment diabetes equation hypoglycemia, Low Blood Glucose Index), and hyperglycemia (time spent above 180 mg/dL at night [TSA > 180], AUC above 180 mg/dL [AUC > 180], glycemic risk assessment diabetes equation hyperglycemia, High Blood Glucose Index [HBGI], and J index). The correlation of GV indices with HbA1c, duration of diabetes, and demographic and biochemical parameters were also assessed. Results: All the CGM-derived measures of GV (SD, MAGE, CONGA, MODD, and %CV), except M value, were significantly higher in the FCPD group than in the T2D group ( P < 0.05). Measures of hyperglycemia (TSA >180, AUC >180, HBGI, and J index) were significantly higher in the FCPD group than in the T2D group ( P < 0.05). The measures of hypoglycemia were not significantly different between the two groups. All the hyperglycemia indices showed a positive correlation with HbA1c in both groups. Conclusions: FCPD is associated with higher GV than is T2D. The findings of higher postprandial glycemic excursions in patients with FCPD could have potential therapeutic implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glycaemic variability in diabetes: clinical and therapeutic implications
Ceriello, A., Monnier, L., & Owens, D. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30136-0 · Cited by 588 · cited 2×
“TSA > 180 mg/dL and AUC > 180 mg/dL represent the duration of hyperglycemia and hyperglycemic exposure, respectively.(21,22) High rates of hypoglycemia were observed in previous studies in patients with diabetes following pancreatic resection.”
BackgroundDiabetes, pancreatogenic diabetes, and pancreatic cancer
Andersen, D. K., Korc, M., Petersen, G. M., Eibl, G., Li, D., Rickels, M. R., Chari, S. T., & Abbruzzese, J. L. (2017) · Diabetes · doi:10.2337/db16-1477 · Cited by 516 · cited 1×
“In addition, impaired incretin secretion due to nutrient indigestion, exocrine insufficiency, presence of insulin resistance, and other coexisting risk factors for type 2 diabetes mellitus (T2D) further disrupt the glucose metabolism.(4,5) Brittle glycemic control could contribute to higher glycemic variability (GV) a…”
BackgroundGlycemic Variability: How Do We Measure It and Why Is It Important?
Suh, S., & Kim, J. H. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.273 · Cited by 439
Glucose Variability; Does It Matter?
Siegelaar, S. E., Holleman, F., Hoekstra, J. B. L., & DeVries, J. H. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0021 · Cited by 409 · cited 1×
“Glycemic variability: SD of the mean of the sensor values, mean amplitude of glycemic excursion (MAGE), continuous overall net glycemic action (CONGA), absolute means of daily differences (MODD), M value, and coefficient of variance (%CV).(17) Hypoglycemia: Glycemic risk assessment diabetes equation (GRADE_hypo), time…”
Woodmansey, C., McGovern, A. P., McCullough, K. A., Whyte, M. B., Munro, N. M., Correa, A. C., Gatenby, P. A. C., Jones, S. A., & de Lusignan, S. (2017) · Diabetes Care · doi:10.2337/dc17-0542 · Cited by 280
Cardoso, C. R. L., Leite, N. C., Moram, C. B. M., & Salles, G. F. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0677-0 · Cited by 222 · cited 1×
“Data from a few studies suggest that GV may confer an independent risk for the development of micro- and macrovascular complications.(8,9) Wide fluctuations in blood glucose levels have been shown to be associated with oxidative stress and endothelial dysfunction, which are key factors in the development of complicati…”
BackgroundImpact of total pancreatectomy: short- and long-term assessment
Barbier, L., Jamal, W., Dokmak, S., Aussilhou, B., Corcos, O., Ruszniewski, P., Belghiti, J., & Sauvanet, A. (2013) · HPB · doi:10.1111/hpb.12054 · Cited by 116
Management of pancreatogenic diabetes: challenges and solutions
Makuc, J. (2016) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s99701 · Cited by 84
The Clinical Outcomes after Total Pancreatectomy
Suzuki, S., Kajiyama, H., Takemura, A., Shimazaki, J., Nishida, K., & Shimoda, M. (2017) · Digestive Surgery · doi:10.1159/000449234 · Cited by 30 · cited 1×
“This discordance could be attributed to three factors: (a) relative preservation of endocrine and exocrine function and counterregulatory responses in FCPD compared to that following total pancreatectomy.(30,31) In this regard, it is interesting to note that an earlier study demonstrated relative preservation of exocr…”
Result
Cited by
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s006 · Cited by 1,403
6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s006 · Cited by 847
6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s006 · Cited by 744
Petrov, M. S., & Basina, M. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-0974 · Cited by 81
Metadata
- Authors
- Shivaprasad, C., Aiswarya, Y., Kejal, S., Sridevi, A., Anupam, B., Ramdas, B., Gautham, K., & Aarudhra, P.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2019-07-07
- Volume
- 15
- Issue
- 1
- Pages
- 134-140
- ISSN
- 1932-2968 (ISSN-L)
- OpenAlex
- W2957436086
- Cited by
- 42
- References
- 9
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus. https://app.cochat.ai/papers/10.1177/1932296819860133
- The paper
- Shivaprasad, C., Aiswarya, Y., Kejal, S., Sridevi, A., Anupam, B., Ramdas, B., Gautham, K., & Aarudhra, P. (2021). Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296819860133
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.